Short answer · Medically reviewed summary · Last updated: 2026-05-08
Paroxysmal Kinesigenic Choreathetosis (PKC), also known as Paroxysmal Kinesigenic Dyskinesia (PKD), is primarily a clinical diagnosis based on a detailed patient history of brief, movement-induced attacks. While there is no single diagnostic test, clinicians rely on identifying characteristic triggers and often use genetic testing for the PRRT2 gene to confirm the diagnosis. How is a diagnosis of Paroxysmal Kinesigenic Choreathetosis established? The diagnostic process for Paroxysmal Kinesigenic Choreathetosis is heavily reliant on a clinical interview.
Paroxysmal Kinesigenic Choreathetosis (PKC), also known as Paroxysmal Kinesigenic Dyskinesia (PKD), is primarily a clinical diagnosis based on a detailed patient history of brief, movement-induced attacks. While there is no single diagnostic test, clinicians rely on identifying characteristic triggers and often use genetic testing for the PRRT2 gene to confirm the diagnosis.
The diagnostic process for Paroxysmal Kinesigenic Choreathetosis is heavily reliant on a clinical interview. Because these episodes are brief and often occur outside the clinic, physicians look for specific patterns. Patients with Paroxysmal Kinesigenic Choreathetosis typically report attacks lasting less than one minute, triggered by sudden voluntary movement, such as standing up quickly or starting to run.
Neurologists often use the criteria established by Bruno et al. to confirm Paroxysmal Kinesigenic Dyskinesia. These criteria include:
If you suspect you have Paroxysmal Kinesigenic Choreathetosis, you should consult a movement disorder specialist (a neurologist with fellowship training in movement disorders). Because Paroxysmal Kinesigenic Dyskinesia is rare, it is frequently misdiagnosed as epilepsy or psychogenic movement disorder. A specialist is essential to differentiate it from other paroxysmal disorders through video-EEG monitoring or MRI imaging to rule out structural causes.
The "diagnostic odyssey" for Paroxysmal Kinesigenic Choreathetosis is common because the symptoms are intermittent and fleeting. At DiseaseMaps.org, our 7 community members understand the frustration of having "normal" test results while experiencing debilitating symptoms. Genetic testing for the PRRT2 gene mutation is now the gold standard, as it is found in approximately 70-80% of familial cases, helping to end the uncertainty of the diagnostic process.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.